{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:09:08Z","timestamp":1792724948087,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56442-4","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:24:27Z","timestamp":1781090667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis, biological evaluation and detailed computational studies of N-sulfonyl indole-based dihydrothiazoles against colorectal carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Zahra","family":"Batool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeyma","family":"Ate\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahri","family":"Akba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah A.","family":"Albekairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"4","key":"56442_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1353\/pbm.2019.0046","volume":"62","author":"DM Hausman","year":"2019","unstructured":"Hausman, D. M. What is cancer?. Perspect. Biol. Med. 62(4), 778\u2013784. https:\/\/doi.org\/10.1353\/pbm.2019.0046 (2019).","journal-title":"Perspect. Biol. Med."},{"issue":"4","key":"56442_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1163\/193724012x640650","volume":"32","author":"FR Schram","year":"2012","unstructured":"Schram, F. R. & Ng, P. K. L. What is cancer?. J. Crustac. Biol. 32(4), 665\u2013672. https:\/\/doi.org\/10.1163\/193724012x640650 (2012).","journal-title":"J. Crustac. Biol."},{"issue":"2-3","key":"56442_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/02841860151116204","volume":"40","author":"P Nygren","year":"2001","unstructured":"Nygren, P. & Care, S.B.-g. What is cancer chemotherapy?. Acta Oncol. 40(2\u20133), 166\u2013174. https:\/\/doi.org\/10.1080\/02841860151116204 (2001).","journal-title":"Acta Oncol."},{"issue":"6A","key":"56442_CR4","first-page":"4601","volume":"19","author":"W Den Otter","year":"1999","unstructured":"Den Otter, W., Root-Bernstein, R. & Koten, J. W. What is cancer? Theories on carcinogenesis. Anticancer Res. 19(6A), 4601\u20134602 (1999).","journal-title":"Anticancer Res."},{"issue":"1","key":"56442_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75(1), 10\u201345. https:\/\/doi.org\/10.3322\/caac.21871 (2025).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"56442_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21877","volume":"75","author":"BW Corn","year":"2025","unstructured":"Corn, B. W. & Feldman, D. B. Cancer statistics, 2025: A hinge moment for optimism to morph into hope?. CA Cancer J. Clin. 75(1), 7\u20139. https:\/\/doi.org\/10.3322\/caac.21877 (2025).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"56442_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"56442_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140153","volume":"1321","author":"B Zengin Kurt","year":"2025","unstructured":"Zengin Kurt, B. et al. Synthesis, cytotoxic evaluation, and in silico studies of novel benzenesulfonamide-thiazolidinone derivatives against colorectal carcinoma. J. Mol. Struct. 1321, 140153. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140153 (2025).","journal-title":"J. Mol. Struct."},{"issue":"2","key":"56442_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55(2), 74\u2013108. https:\/\/doi.org\/10.3322\/canjclin.55.2.74 (2005).","journal-title":"CA Cancer J. Clin."},{"issue":"22","key":"56442_CR10","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1039\/D6RA00514D","volume":"16","author":"V Walhekar","year":"2026","unstructured":"Walhekar, V. et al. From in silico and machine learning model to validation: Discovery of novel amide-functionalized imidazopyridines as PIM-1 kinase inhibitors using an integrated ligand and structure-based hopping approach. RSC Adv. 16(22), 20224\u201320240. https:\/\/doi.org\/10.1039\/D6RA00514D (2026).","journal-title":"RSC Adv."},{"key":"56442_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118060","volume":"119","author":"B Zengin Kurt","year":"2025","unstructured":"Zengin Kurt, B., \u00d6zmen, \u00d6., \u00d6zt\u00fcrk Civelek, D., \u015eenol, H. & Sonmez, F. Exploring anticancer properties of new triazole-linked benzenesulfonamide derivatives against colorectal carcinoma: Synthesis, cytotoxicity, and in silico insights. Bioorg. Med. Chem. 119, 118060. https:\/\/doi.org\/10.1016\/j.bmc.2025.118060 (2025).","journal-title":"Bioorg. Med. Chem."},{"key":"56442_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117915","volume":"296","author":"EN Ay","year":"2025","unstructured":"Ay, E. N. et al. Synthesis, characterization, in vitro and in silico investigations of novel 1,2,3-triazole substituted salicylic acid phenolic hydrazones hybrids targeting TGF-\u03b22 expression in colorectal carcinoma. Eur. J. Med. Chem. 296, 117915. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117915 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"56442_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109118","volume":"166","author":"AS Di\u015fer","year":"2025","unstructured":"Di\u015fer, A. S. et al. Synthesis of indomethacin thiadiazole urea derivatives and determination of GSTA4 inhibition and cytotoxic activity against colorectal carcinoma. Bioorg. Chem. 166, 109118. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109118 (2025).","journal-title":"Bioorg. Chem."},{"issue":"18","key":"56442_CR14","doi-asserted-by":"publisher","first-page":"9420","DOI":"10.1039\/d4fo02346c","volume":"15","author":"YL Jiang","year":"2024","unstructured":"Jiang, Y. L. et al. Docosahexaenoic acid inhibits the invasion and migration of colorectal cancer by reversing EMT through the TGF-\u03b21\/Smad signaling pathway. Food Funct. 15(18), 9420\u20139433. https:\/\/doi.org\/10.1039\/d4fo02346c (2024).","journal-title":"Food Funct."},{"issue":"Suppl 2","key":"56442_CR15","first-page":"470","volume":"29","author":"K Chouliaras","year":"2022","unstructured":"Chouliaras, K., Oshi, M. & Takabe, K. Increased angiogenesis, lymphangiogenesis as well as TGF-beta signaling pathways in colorectal peritoneal metastases. Ann. Surg. Oncol. 29(Suppl 2), 470\u2013471 (2022).","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"56442_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020334","volume":"26","author":"AN Abdalla","year":"2021","unstructured":"Abdalla, A. N. et al. Chemosensitization of HT29 and HT29-5FU cell lines by a combination of a multi-tyrosine kinase inhibitor and 5FU downregulates ABCC1 and inhibits PIK3CA in light of their importance in Saudi colorectal cancer. Molecules 26(2), 334. https:\/\/doi.org\/10.3390\/molecules26020334 (2021).","journal-title":"Molecules"},{"issue":"3","key":"56442_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188725","volume":"1877","author":"V Walhekar","year":"2022","unstructured":"Walhekar, V. et al. Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877(3), 188725. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188725 (2022).","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"56442_CR18","doi-asserted-by":"publisher","DOI":"10.2174\/1570178617666200225102939","author":"S Shahinshavali","year":"2020","unstructured":"Shahinshavali, S., Guttikonda, V., Sreenivasulu, R. & Venkata Basaveswara Rao, M. Design, synthesis and anticancer evaluation of acetamides comprising 1,2,3-triazole, 1,3,4-thiadiazole and isothiazolo[4,3-b]pyridine rings. Lett. Org. Chem. https:\/\/doi.org\/10.2174\/1570178617666200225102939 (2020).","journal-title":"Lett. Org. Chem."},{"key":"56442_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106412","volume":"133","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. 1H-Indazoles derivatives targeting PI3K\/AKT\/mTOR pathway: Synthesis, anti-tumor effect and molecular mechanism. Bioorg. Chem. 133, 106412. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106412 (2023).","journal-title":"Bioorg. Chem."},{"issue":"3","key":"56442_CR20","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/jcp.30655","volume":"237","author":"MJ Sanaei","year":"2022","unstructured":"Sanaei, M. J. et al. The PI3K\/Akt\/mTOR axis in colorectal cancer: Oncogenic alterations, non-coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles. J. Cell. Physiol. 237(3), 1720\u20131752. https:\/\/doi.org\/10.1002\/jcp.30655 (2022).","journal-title":"J. Cell. Physiol."},{"key":"56442_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13060185","author":"S Khan","year":"2025","unstructured":"Khan, S. et al. Tumor Necrosis Factor-Alpha\u2019s role in the pathophysiology of colon cancer. Diseases https:\/\/doi.org\/10.3390\/diseases13060185 (2025).","journal-title":"Diseases"},{"issue":"1","key":"56442_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Signaling pathways involved in colorectal cancer: Pathogenesis and targeted therapy. Signal Transduct. Target. Ther. 9(1), 266. https:\/\/doi.org\/10.1038\/s41392-024-01953-7 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"56442_CR23","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1134\/S1070363219080279","volume":"89","author":"IS Murthy","year":"2019","unstructured":"Murthy, I. S., Sreenivasulu, R., Alluraiah, G. & Ramesh Raju, R. Design, synthesis, and anticancer activity of 1,2,3-triazole linked 1,2-isoxazole-imidazo[4,5-b]pyridine derivatives. Russ. J. Gen. Chem. 89(8), 1718\u20131723. https:\/\/doi.org\/10.1134\/S1070363219080279 (2019).","journal-title":"Russ. J. Gen. Chem."},{"key":"56442_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2026.109487","volume":"170","author":"V Walhekar","year":"2026","unstructured":"Walhekar, V. et al. Reconnecting new tetrahydrobenzothieno-4-pyrimidine amides as potent PIM-1 kinase inhibitors via an integrated ligand, machine learning model and structure based scaffold hopping: In vitro anti-tumor investigations. Bioorg. Chem. 170, 109487. https:\/\/doi.org\/10.1016\/j.bioorg.2026.109487 (2026).","journal-title":"Bioorg. Chem."},{"issue":"39","key":"56442_CR25","doi-asserted-by":"publisher","first-page":"28524","DOI":"10.1039\/D4RA05015K","volume":"14","author":"Z Batool","year":"2024","unstructured":"Batool, Z. et al. Design, synthesis, and in vitro and in silico study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors. RSC Adv. 14(39), 28524\u201328542 (2024).","journal-title":"RSC Adv."},{"issue":"1","key":"56442_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75100-1","volume":"14","author":"Z Batool","year":"2024","unstructured":"Batool, Z. et al. Design, synthesis, QSAR modelling and molecular dynamic simulations of N-tosyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors. Sci. Rep. 14(1), 25754 (2024).","journal-title":"Sci. Rep."},{"key":"56442_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00706-016-1750-6","author":"R Sreenivasulu","year":"2016","unstructured":"Sreenivasulu, R. et al. Synthesis, antitumor evaluation, and molecular docking studies of indole\u2013indazolyl hydrazide\u2013hydrazone derivatives. Monatshefte fuer Chemie\/Chem. Mon. https:\/\/doi.org\/10.1007\/s00706-016-1750-6 (2016).","journal-title":"Monatshefte fuer Chemie\/Chem. Mon."},{"key":"56442_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.14233\/ajchem.2018.21114","volume":"30","author":"D Rudavath","year":"2018","unstructured":"Rudavath, D., Sreenivasulu, R., Pinapati, S. & Raju, R. Synthesis and antitumor evaluation of novel 5-bromo indole-aryl keto hydrazide-hydrazone analogues. Asian J. Chem. 30, 1201\u20131204. https:\/\/doi.org\/10.14233\/ajchem.2018.21114 (2018).","journal-title":"Asian J. Chem."},{"key":"56442_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11696-017-0372-8","volume":"72","author":"R Sreenivasulu","year":"2018","unstructured":"Sreenivasulu, R. et al. Synthesis, anticancer evaluation and molecular docking studies of bis(indolyl) triazinones, Nortopsentin analogs. Chem. Pap. 72, 1\u201310. https:\/\/doi.org\/10.1007\/s11696-017-0372-8 (2018).","journal-title":"Chem. Pap."},{"issue":"6","key":"56442_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.bmc.2019.02.002","volume":"27","author":"R Sreenivasulu","year":"2019","unstructured":"Sreenivasulu, R., Reddy, K. T., Sujitha, P., Kumar, C. G. & Raju, R. R. Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl)hydrazide-hydrazone derivatives. Bioorg. Med. Chem. 27(6), 1043\u20131055. https:\/\/doi.org\/10.1016\/j.bmc.2019.02.002 (2019).","journal-title":"Bioorg. Med. Chem."},{"key":"56442_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109252","volume":"167","author":"Z Batool","year":"2025","unstructured":"Batool, Z. et al. Dual targeting of neuroblastoma and cholinesterase by morpholino\/pyrrolidino-sulfonyl-indole thiosemicarbazones: Synthesis, characterization, enzyme inhibition, cytotoxicity, docking and dynamics studies. Bioorg. Chem. 167, 109252. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109252 (2025).","journal-title":"Bioorg. Chem."},{"key":"56442_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2024.101282","author":"BT Sridhar","year":"2024","unstructured":"Sridhar, B. T. et al. A concise review on recent development of indole derivatives for anticancer activities. J. Indian Chem. Soc. https:\/\/doi.org\/10.1016\/j.jics.2024.101282 (2024).","journal-title":"J. Indian Chem. Soc."},{"key":"56442_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.32383\/appdr\/178491","volume":"81","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y., Tang, Y., Luo, Q., Hu, Y. & Peng, W. Indole-3-carboxylic acid enhanced anti-cancer potency of Doxorubicin via induction of cellular senescence in colorectal cells. Acta Poloniae Pharmaceutica Drug Res. 81, 109\u2013121. https:\/\/doi.org\/10.32383\/appdr\/178491 (2024).","journal-title":"Acta Poloniae Pharmaceutica Drug Res."},{"issue":"6","key":"56442_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2023.104776","volume":"16","author":"D Hu","year":"2023","unstructured":"Hu, D. et al. Design, synthesis and biological activity of novel chalcone derivatives containing indole. Arab. J. Chem. 16(6), 104776. https:\/\/doi.org\/10.1016\/j.arabjc.2023.104776 (2023).","journal-title":"Arab. J. Chem."},{"key":"56442_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2023.101492","volume":"35","author":"AS Baez-Gonzalez","year":"2023","unstructured":"Baez-Gonzalez, A. S. et al. Functional effect of indole-3 carbinol in the viability and invasive properties of cultured cancer cells. Biochem. Biophys. Rep. 35, 101492. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101492 (2023).","journal-title":"Biochem. Biophys. Rep."},{"key":"56442_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00706-015-1448-1","author":"I Hatti","year":"2015","unstructured":"Hatti, I., Sreenivasulu, R., Jadav, S., Ahsan, M. & Raju, R. Synthesis and biological evaluation of 1,3,4-oxadiazole-linked bisindole derivatives as anticancer agents. Monatshefte f\u00fcr Chemie Chem. Mon. https:\/\/doi.org\/10.1007\/s00706-015-1448-1 (2015).","journal-title":"Monatshefte f\u00fcr Chemie Chem. Mon."},{"issue":"1","key":"56442_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2022.101327","volume":"33","author":"M Aydin","year":"2023","unstructured":"Aydin, M. et al. In vitro antifungal and antibiofilm activities of novel sulfonyl hydrazone derivatives against Candida spp. J. Med. Mycol. 33(1), 101327. https:\/\/doi.org\/10.1016\/j.mycmed.2022.101327 (2023).","journal-title":"J. Med. Mycol."},{"issue":"13","key":"56442_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202300241","volume":"8","author":"FS Tokali","year":"2023","unstructured":"Tokali, F. S., Taslimi, P., Sadeghian, N., Taskin-Tok, T. & G\u00fcl\u00e7in, I. Synthesis, characterization, bioactivity impacts of new Anthranilic Acid Hydrazones containing Aryl Sulfonate moiety as Fenamate isosteres. ChemSelect 8(13), e202300241. https:\/\/doi.org\/10.1002\/slct.202300241 (2023).","journal-title":"ChemSelect"},{"issue":"3","key":"56442_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.13005\/ojc\/390323","volume":"39","author":"S Donthukurthi","year":"2023","unstructured":"Donthukurthi, S., Patel, D. J., Patel, R. I. & Vyas, P. J. Synthesis, characterization and antimicrobial activity of thiazolo-oxazine fused heterocyclic derivatives, based on benzene sulfonyl hydrazide. Orient. J. Chem. 39(3), 721\u2013726. https:\/\/doi.org\/10.13005\/ojc\/390323 (2023).","journal-title":"Orient. J. Chem."},{"key":"56442_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108717","author":"Z Batool","year":"2025","unstructured":"Batool, Z. et al. N-hexylsulfonyl indole based thiosemicarbazones as potent and selective ecto-5\u2032-nucleotidase and NTPDase inhibitors. Bioorg. Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108717 (2025).","journal-title":"Bioorg. Chem."},{"issue":"9","key":"56442_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70098","volume":"358","author":"H Aftab","year":"2025","unstructured":"Aftab, H. et al. Synthesis, biological evaluation and molecular docking studies of novel 4-Propylsulfonylpiperazines-based thiosemicarbazones as Ecto-5\u2032-Nucleotidase and NTPDase inhibitors. Arch. Pharm. 358(9), e70098 (2025).","journal-title":"Arch. Pharm."},{"key":"56442_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.139089","volume":"1317","author":"AR Pasha","year":"2024","unstructured":"Pasha, A. R. et al. Synthesis, in vitro \u03b1-glucosidase inhibitory potential and in silico study of 2\u2011chloro pyridine incorporated thiosemicarbazones. J. Mol. Struct. 1317, 139089 (2024).","journal-title":"J. Mol. Struct."},{"key":"56442_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109364","volume":"168","author":"H Aftab","year":"2026","unstructured":"Aftab, H. et al. A series of 4-thiomorpholinophenyl-thiosemicarbazones as cholinesterase inhibitors with anti-neuroblastoma effects. Bioorg. Chem. 168, 109364. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109364 (2026).","journal-title":"Bioorg. Chem."},{"key":"56442_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140197","volume":"1321","author":"A Farzaliyeva","year":"2025","unstructured":"Farzaliyeva, A. et al. Synthesis and biological studies of acetophenone-based novel chalcone, semicarbazone, thiosemicarbazone and indolone derivatives: Structure-activity relationship, molecular docking, molecular dynamics, and kinetic studies. J. Mol. Struct. 1321, 140197. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140197 (2025).","journal-title":"J. Mol. Struct."},{"key":"56442_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117030","volume":"281","author":"GLS Sousa","year":"2025","unstructured":"Sousa, G. L. S. et al. Discovery of novel thiosemicarbazone-acridine targeting butyrylcholinesterase with antioxidant, metal complexing and neuroprotector abilities as potential treatment of Alzheimer\u2019s disease: In vitro, in vivo, and in silico studies. Eur. J. Med. Chem. 281, 117030. https:\/\/doi.org\/10.1016\/j.ejmech.2024.117030 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"56442_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108118","volume":"155","author":"J Eshal","year":"2025","unstructured":"Eshal, J. et al. Synthesis, biological evaluation, and in silico studies of phenyl naphthalene-2-sulfonate derived thiosemicarbazones as potential carbonic anhydrase inhibitors. Bioorg. Chem. 155, 108118. https:\/\/doi.org\/10.1016\/j.bioorg.2024.108118 (2025).","journal-title":"Bioorg. Chem."},{"issue":"7","key":"56442_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70050","volume":"358","author":"U Farooq","year":"2025","unstructured":"Farooq, U. et al. Design, synthesis, in vitro, and in silico studies of 5-(Diethylamino)-2-Formylphenyl Naphthalene-2-Sulfonate based thiosemicarbazones as potent Anti-Alzheimer agents. Arch. Pharm. 358(7), e70050. https:\/\/doi.org\/10.1002\/ardp.70050 (2025).","journal-title":"Arch. Pharm."},{"issue":"1","key":"56442_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30010129","volume":"30","author":"A Czylkowska","year":"2025","unstructured":"Czylkowska, A. et al. Thiosemicarbazone-based compounds: A promising scaffold for developing antibacterial, antioxidant, and anticancer therapeutics. Molecules 30(1), 129. https:\/\/doi.org\/10.3390\/molecules30010129 (2025).","journal-title":"Molecules"},{"issue":"10","key":"56442_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70116","volume":"358","author":"S Raza","year":"2025","unstructured":"Raza, S. et al. Targeting lung cancer: Synthesis, characterization, enzyme inhibition, and antiproliferative activity of 1H-Benzo[f]chromen-1-One-Thiosemicarbazones supported by molecular docking. Arch. Pharm. 358(10), e70116. https:\/\/doi.org\/10.1002\/ardp.70116 (2025).","journal-title":"Arch. Pharm."},{"key":"56442_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102839","volume":"18","author":"GV Kumar","year":"2025","unstructured":"Kumar, G. V. et al. Rational design, anticancer evaluation and molecular docking studies of aryl amide linked oxazole-pyrazine-pyridine derivatives. Res. Chem. 18, 102839. https:\/\/doi.org\/10.1016\/j.rechem.2025.102839 (2025).","journal-title":"Res. Chem."},{"key":"56442_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106172","volume":"129","author":"R El-Haggar","year":"2022","unstructured":"El-Haggar, R. et al. 3-Substituted-2,3-Dihydrothiazole as a promising scaffold to design EGFR inhibitors. Bioorg. Chem. 129, 106172. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106172 (2022).","journal-title":"Bioorg. Chem."},{"key":"56442_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118266","volume":"302","author":"R Teng","year":"2026","unstructured":"Teng, R. et al. 4-Hydroxy-2,5-dihydrothiazole derivatives as a new class of small-molecule antibiotics for MRSA: AI-integrated design, chemical synthesis and biological evaluation. Eur. J. Med. Chem. 302, 118266. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118266 (2026).","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"56442_CR53","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/ph16101483","volume":"16","author":"G Andreozzi","year":"2023","unstructured":"Andreozzi, G. et al. Design, synthesis and biological evaluation of novel N-Arylpiperazines containing a 4,5-Dihydrothiazole ring. Pharmaceuticals 16(10), 1483. https:\/\/doi.org\/10.3390\/ph16101483 (2023).","journal-title":"Pharmaceuticals"},{"issue":"43","key":"56442_CR54","doi-asserted-by":"publisher","first-page":"31607","DOI":"10.1039\/d4ra06146b","volume":"14","author":"AF Kassem","year":"2024","unstructured":"Kassem, A. F., Sediek, A. A., Omran, M. M., Foda, D. S. & Al-Ashmawy, A. A. K. Design, synthesis and in vitro anti-proliferative evaluation of new pyridine-2,3-dihydrothiazole\/thiazolidin-4-one hybrids as dual CDK2\/GSK3\u03b2 kinase inhibitors. RSC Adv. 14(43), 31607\u201331623. https:\/\/doi.org\/10.1039\/d4ra06146b (2024).","journal-title":"RSC Adv."},{"issue":"7","key":"56442_CR55","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/10426507.2023.2189252","volume":"198","author":"S Goswami","year":"2023","unstructured":"Goswami, S. & Chaudhary, R. P. Expeditious mechanochemical conversion of dihydronaphthalenyl-N-phenylhydrazine-1-carbothioamides into hydrazono-thiazolidin-4-one and hydrazono-dihydrothiazole derivatives-spectroscopic, DFT, X-ray diffraction, and antibacterial studies. Phosphorus Sulfur Silicon Relat. Elem. 198(7), 615\u2013626. https:\/\/doi.org\/10.1080\/10426507.2023.2189252 (2023).","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"56442_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202500288","author":"G Andreozzi","year":"2025","unstructured":"Andreozzi, G. et al. Novel 4,5-Dihydrothiazole-Phenylpiperazine derivatives: Synthesis, docking studies and pharmacological evaluation as serotonergic agents. ChemMedChem https:\/\/doi.org\/10.1002\/cmdc.202500288 (2025).","journal-title":"ChemMedChem"},{"key":"56442_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202300944","author":"D Osmaniye","year":"2023","unstructured":"Osmaniye, D. et al. Synthesis of Imidazole-2,3-dihydrothiazole compounds as VEGFR-2 inhibitors and their support with in silico studies. Chem. Biodivers. https:\/\/doi.org\/10.1002\/cbdv.202300944 (2023).","journal-title":"Chem. Biodivers."},{"issue":"16","key":"56442_CR58","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1080\/00397911.2024.2387121","volume":"54","author":"AA Sediek","year":"2024","unstructured":"Sediek, A. A., Kassem, A. F., Abdel-Aziz, M. S. & Younis, A. Synthesis, antimicrobial activity, and biofilm inhibition studies of 1,2,3-triazole-containing 2,3-dihydrothiazole. Synth. Commun. 54(16), 1376\u20131387. https:\/\/doi.org\/10.1080\/00397911.2024.2387121 (2024).","journal-title":"Synth. Commun."},{"key":"56442_CR59","doi-asserted-by":"publisher","DOI":"10.2174\/1570178613666161021105317","author":"S Madhavi","year":"2016","unstructured":"Madhavi, S., Sreenivasulu, R., Ansari, M., Ahsan, M. & Raju, R. Synthesis, biological evaluation and molecular docking studies of pyridine incorporated chalcone derivatives as anticancer agents. Lett. Org. Chem. https:\/\/doi.org\/10.2174\/1570178613666161021105317 (2016).","journal-title":"Lett. Org. Chem."},{"key":"56442_CR60","doi-asserted-by":"crossref","unstructured":"Sayed, A. R., Gomha, S. M., Taher, E. A., Muhammad, Z. A., El-Seedi, H. R., Gaber, H. M. & Ahmed, M. M. One-pot synthesis of novel thiazoles as potential anti-cancer agents. Drug Design Dev. Ther. 1363\u20131375 (2020).","DOI":"10.2147\/DDDT.S221263"},{"key":"56442_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.127798","volume":"1207","author":"AH Mohamed","year":"2020","unstructured":"Mohamed, A. H. & Ramadan, M. Synthesis and colon anticancer activity of some novel thiazole\/-2-quinolone derivatives. J. Mol. Struct. 1207, 127798 (2020).","journal-title":"J. Mol. Struct."},{"issue":"1","key":"56442_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68815-8","volume":"14","author":"NM Abdelazeem","year":"2024","unstructured":"Abdelazeem, N. M., Gouhar, S. A., Fahmy, C. A., Elshahid, Z. A. & El-Hussieny, M. Evaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25. Sci. Rep. 14(1), 20045 (2024).","journal-title":"Sci. Rep."},{"issue":"21","key":"56442_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25215190","volume":"25","author":"B Sever","year":"2020","unstructured":"Sever, B. et al. In vitro and in silico evaluation of anticancer activity of new indole-based 1, 3, 4-oxadiazoles as EGFR and COX-2 inhibitors. Molecules 25(21), 5190 (2020).","journal-title":"Molecules"},{"issue":"1","key":"56442_CR64","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/10406638.2021.2021256","volume":"43","author":"R Sireesha","year":"2023","unstructured":"Sireesha, R. et al. Synthesis of substituted aryl incorporated Oxazolo[4,5-b]Pyridine-Triazole derivatives: Anticancer evaluation and molecular docking studies. Polycycl. Aromat. Compd. 43(1), 915\u2013932. https:\/\/doi.org\/10.1080\/10406638.2021.2021256 (2023).","journal-title":"Polycycl. Aromat. Compd."},{"key":"56442_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s11696-024-03861-0","author":"E Devi","year":"2024","unstructured":"Devi, E. et al. Design, synthesis, in-vitro and in-silico anticancer studies on amide derivatives of 1,3,4-oxadiazole-isoxazol-pyridine-benzimidazole. Chem. Pap. https:\/\/doi.org\/10.1007\/s11696-024-03861-0 (2024).","journal-title":"Chem. Pap."},{"key":"56442_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-020-02638-w","author":"K-K Mak","year":"2021","unstructured":"Mak, K.-K. et al. Synthesis and anticancer evaluation of amide derivativesof imidazo-pyridines. Med. Chem. Res. https:\/\/doi.org\/10.1007\/s00044-020-02638-w (2021).","journal-title":"Med. Chem. Res."},{"key":"56442_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118301","volume":"129","author":"I Munir","year":"2025","unstructured":"Munir, I. et al. Synthesis of 6-ethoxyphenyl 4-fluorobenzenesulfonate-tagged thiosemicarbazones as carbonic anhydrase inhibitors: In-vitro and in silico approach. Bioorg. Med. Chem. 129, 118301. https:\/\/doi.org\/10.1016\/j.bmc.2025.118301 (2025).","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"56442_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-18735-y","volume":"15","author":"H Aftab","year":"2025","unstructured":"Aftab, H. et al. Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones. Sci. Rep. 15(1), 33402. https:\/\/doi.org\/10.1038\/s41598-025-18735-y (2025).","journal-title":"Sci. Rep."},{"issue":"12","key":"56442_CR69","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/00397911.2025.2511819","volume":"55","author":"SK Ramadan","year":"2025","unstructured":"Ramadan, S. K., Ali, A. T., Gomha, S. M. & El-Helw, E. A. E. Design, synthesis, and in silico studies of pyrazolyl-thiazole and thiazolidinone hybrids as potential antiproliferative agents. Synth. Commun. 55(12), 931\u2013951. https:\/\/doi.org\/10.1080\/00397911.2025.2511819 (2025).","journal-title":"Synth. Commun."},{"key":"56442_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2025.128421","volume":"437","author":"S Gerni","year":"2025","unstructured":"Gerni, S., Demir, Y. & Din\u00e7er, B. Multitarget inhibition of diabetic enzymes by thiazole carboxylic acids: Experimental and computational approaches. J. Mol. Liq. 437, 128421. https:\/\/doi.org\/10.1016\/j.molliq.2025.128421 (2025).","journal-title":"J. Mol. Liq."},{"key":"56442_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140702","volume":"1322","author":"F \u00c7ak\u0131r","year":"2025","unstructured":"\u00c7ak\u0131r, F. et al. Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studies. J. Mol. Struct. 1322, 140702. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140702 (2025).","journal-title":"J. Mol. Struct."},{"issue":"39","key":"56442_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202302448","volume":"8","author":"H \u015eenol","year":"2023","unstructured":"\u015eenol, H. & \u00c7ak\u0131r, F. 3-Amino-thiophene-2-carbohydrazide derivatives as anti colon cancer agents: Synthesis, characterization, in-silico and in-vitro biological activity studies. ChemistrySelect 8(39), e202302448 (2023).","journal-title":"ChemistrySelect"},{"key":"56442_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2025.126987","volume":"423","author":"T Murugan","year":"2025","unstructured":"Murugan, T. et al. Insights into a tetra dentate Schiff base complex: Structural, electronic and antifungal target interactions. J. Mol. Liq. 423, 126987. https:\/\/doi.org\/10.1016\/j.molliq.2025.126987 (2025).","journal-title":"J. Mol. Liq."},{"key":"56442_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140406","volume":"1322","author":"H Mu\u011flu","year":"2025","unstructured":"Mu\u011flu, H. Synthesis, spectroscopic characterization, DFT studies and antioxidant activity of new 5-substituted isatin\/thiosemicarbazones. J. Mol. Struct. 1322, 140406. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140406 (2025).","journal-title":"J. Mol. Struct."},{"key":"56442_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.143306","volume":"1347","author":"A Ullah","year":"2025","unstructured":"Ullah, A. et al. Synthesis, in vitro tyrosinase inhibition, molecular docking, ADMET and DFT studies of ether containing Schiff base derivatives of naproxen. J. Mol. Struct. 1347, 143306. https:\/\/doi.org\/10.1016\/j.molstruc.2025.143306 (2025).","journal-title":"J. Mol. Struct."},{"key":"56442_CR76","doi-asserted-by":"publisher","unstructured":"Shahab, N., Alam, A., Elhenawy, A., Ayaz, D., Khan, M., Rehman, N., Talab, F., Al-Harrasi, A., Latif, A., Ali, M. & Ahmad, M. Hydrazone-Schiff base derivatives bearing polyhydroquinoline scaffold as potent anti-microbial agents: in vitro and molecular docking and DFT insights. J. Comput. Biophys. Chem (2025). https:\/\/doi.org\/10.1142\/S2737416525500632","DOI":"10.1142\/S2737416525500632"},{"issue":"10","key":"56442_CR77","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1039\/D5RA10080A","volume":"16","author":"W Zareen","year":"2026","unstructured":"Zareen, W. et al. Synthesis, multi-target evaluation and DFT analysis of 6-hydroxychromone derived hydrazones with carbonic anhydrase I\u2013II\/acetylcholinesterase inhibition and antioxidant activity. Rsc Adv. 16(10), 8807\u20138827. https:\/\/doi.org\/10.1039\/D5RA10080A (2026).","journal-title":"Rsc Adv."},{"issue":"20","key":"56442_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202300481","volume":"8","author":"H \u015eenol","year":"2023","unstructured":"\u015eenol, H., A\u011fg\u00fcl, A. G. & Atasoy, S. Synthesis, characterization, molecular docking and biological studies of Thiazolidin-4-one derivatives as anti-breast-cancer agents. ChemistrySelect 8(20), e202300481. https:\/\/doi.org\/10.1002\/slct.202300481 (2023).","journal-title":"ChemistrySelect"},{"issue":"7","key":"56442_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70048","volume":"358","author":"H \u015eenol","year":"2025","unstructured":"\u015eenol, H. et al. 2-Propyl-3-Aminoquinazoline-4(3H)-one derivatives as potential Androgen Receptor inhibitors: Synthesis and cytotoxicity against PC3 cell line via in vitro and in silico studies. Arch. Pharm. 358(7), e70048. https:\/\/doi.org\/10.1002\/ardp.70048 (2025).","journal-title":"Arch. Pharm."},{"issue":"17","key":"56442_CR80","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1055\/a-2541-1072","volume":"36","author":"\u015e Ate\u015fo\u011flu","year":"2025","unstructured":"Ate\u015fo\u011flu, \u015e et al. Synthesis, characterization and in vitro and in silico biological evaluation of new Mannich-based rhodanine and Thiazolidine-2,4-dione derivatives as potential anti-lung-cancer agents. Synlett 36(17), 2939\u20132947. https:\/\/doi.org\/10.1055\/a-2541-1072 (2025).","journal-title":"Synlett"},{"issue":"3","key":"56442_CR81","doi-asserted-by":"publisher","first-page":"114","DOI":"10.25135\/acg.oc.84.20.09.1792","volume":"13","author":"H \u015eenol","year":"2020","unstructured":"\u015eenol, H. et al. Synthesis of new fatty acid derivatives of oleanane and ursane triterpenoids and investigation of their in vitro cytotoxic effects on 3T3 fibroblast and PC3 prostate cancer cell linesLines. Org. Commun. 13(3), 114\u2013126. https:\/\/doi.org\/10.25135\/acg.oc.84.20.09.1792 (2020).","journal-title":"Org. Commun."},{"issue":"15","key":"56442_CR82","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1080\/14786419.2022.2051170","volume":"37","author":"H \u015eenol","year":"2023","unstructured":"\u015eenol, H. et al. Synthesis of ursolic acid arylidene-hydrazide hybrid compounds and investigation of their cytotoxic and antimicrobial effects. Nat. Prod. Res. 37(15), 2500\u20132507. https:\/\/doi.org\/10.1080\/14786419.2022.2051170 (2023).","journal-title":"Nat. Prod. Res."},{"issue":"6","key":"56442_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202303927","volume":"9","author":"H \u015eenol","year":"2024","unstructured":"\u015eenol, H. 4-Furfuryloxymethyl-1,2,3-triazol-1-yl-acetohydrazide hybrids as cholinesterase and carbonic anhydrase inhibitors: Synthesis, characterization and comprehensive biological activity studies. ChemistrySelect 9(6), e202303927. https:\/\/doi.org\/10.1002\/slct.202303927 (2024).","journal-title":"ChemistrySelect"},{"key":"56442_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202500269","author":"G \u00c7elik Turgut","year":"2025","unstructured":"\u00c7elik Turgut, G., Pepe, N. A., Ekiz, Y. C., \u015eenol, H. & \u015een, A. Therapeutic potential of nitrogen-substituted oleanolic acid derivatives in neuroinflammatory and cytokine pathways: Insights from cell-based and computational models. Chem. Biodivers. https:\/\/doi.org\/10.1002\/cbdv.202500269 (2025).","journal-title":"Chem. Biodivers."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56442-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:47:06Z","timestamp":1781257626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56442-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56442"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56442-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this manuscript, generative AI-assisted tools were used to improve the language and readability of the text.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"18334"}}